Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome

by Andrea Sarkozy, Tim Boussy, Georgios Kourgiannides, Gian-Battista Chierchia, Sergio Richter, Tom De Potter, Peter Geelen, Francis Wellens, Marieke Dingena

Spreeuwenberg, and Pedro Brugada

EHJVolume 28(3):334-344

February 5, 2007

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Examples of positive ajmaline test results.

Andrea Sarkozy et al. Eur Heart J 2007;28:334-344

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

(A) Kaplan–Meier appropriate shock-free survival analysis in the study population.

Andrea Sarkozy et al. Eur Heart J 2007;28:334-344

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Example of initiation of monomorphic VT in a 64-year-old male patient taking quinidine therapy.

Andrea Sarkozy et al. Eur Heart J 2007;28:334-344

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

(A) Kaplan–Meier IS-free survival analysis in the study population.

Andrea Sarkozy et al. Eur Heart J 2007;28:334-344

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Examples of IS for atrial arrhythmias with fast ventricular rates.

Andrea Sarkozy et al. Eur Heart J 2007;28:334-344

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org